서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 21 of 21

Issue DateTitle / Author(s) / CitationFileAltmetrics
2001-01
CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface
DOI
2005-04
[6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin
DOI
2006-07
Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking IκB kinase activity

Kundu, Joydeb Kumar; Shin, Young Kee; Kim, Sung Hoon; Surh, Young-Joon

Carcinogenesis, Vol.27 No.7, pp.1465-1474

DOI
2006-11
Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets

Kundu, Joydeb Kumar; Shin, Young Kee; Surh, Young-Joon

Biochemical Pharmacology, Vol.72 No.11, pp.1506-1515

DOI
2009-01
Inhibitory effects of oligonol on phorbol ester-induced tumor promotion and COX-2 expression in mouse skin: NF-κB and C/EBP as potential targets
DOI
2009-10
Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: Eukaryotic elongation factor 1A2 as a potential target
DOI
2011-03
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: Pathological implication in tumorigenesis
view fileDOI
2017-03
Essential role of DNA methyltransferase 1-mediated transcription of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
DOI
2019-07
Therapeutic efficacy of ABN401, highly selective c-MET inhibitor, in NSCLC with MET-amplified AND/OR EGFR mutation
DOI
2019-08
Phenotype-based discovery of a HeLa-specific cytotoxic molecule that downregulates HPV-mediated signaling pathways: Via oxidative damage
DOI
2020-09
Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses
DOI
2021-01
Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing
DOI
2021-01
A novel immune prognostic index for stratification of high-risk patients with early breast cancer
DOI
2021-02
Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer
DOI
2021-12
NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions
DOI
2022-04
Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling
DOI
2022-04
Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer
DOI
2022-06
SMAD4 Controls Cancer Cell Metabolism by Regulating Methylmalonic Aciduria Cobalamin Deficiency (cbl) B Type
DOI
2022-06
Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors

Mekonnen, Negesse; Yang, Hobin; Shin, Young Kee

Frontiers in Oncology, Vol.12, p. 880643

DOI
2023-10
Oxygen-independent stabilization of HIF-2a in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1
DOI
2024-01
c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer
view fileDOI
1